
Innospec Inc. (NASDAQ:IOSP - Free Report) - Stock analysts at Seaport Res Ptn decreased their Q3 2026 earnings estimates for Innospec in a research report issued to clients and investors on Thursday, August 7th. Seaport Res Ptn analyst M. Harrison now anticipates that the specialty chemicals company will post earnings per share of $1.53 for the quarter, down from their previous estimate of $1.60. Seaport Res Ptn currently has a "Strong-Buy" rating on the stock. The consensus estimate for Innospec's current full-year earnings is $6.18 per share. Seaport Res Ptn also issued estimates for Innospec's Q4 2026 earnings at $1.79 EPS.
Innospec (NASDAQ:IOSP - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The specialty chemicals company reported $1.26 EPS for the quarter, topping analysts' consensus estimates of $1.17 by $0.09. The business had revenue of $439.70 million during the quarter, compared to analysts' expectations of $440.70 million. Innospec had a net margin of 1.08% and a return on equity of 10.89%. The business's quarterly revenue was up 1.1% on a year-over-year basis. During the same period last year, the company posted $1.39 earnings per share.
Separately, Wall Street Zen cut shares of Innospec from a "buy" rating to a "hold" rating in a report on Tuesday, May 6th.
View Our Latest Analysis on Innospec
Innospec Stock Down 0.7%
NASDAQ:IOSP traded down $0.61 during trading hours on Monday, reaching $82.86. The company had a trading volume of 28,132 shares, compared to its average volume of 203,243. The firm has a market cap of $2.06 billion, a price-to-earnings ratio of 106.21 and a beta of 1.07. The business's 50-day simple moving average is $84.42 and its two-hundred day simple moving average is $91.80. Innospec has a twelve month low of $74.10 and a twelve month high of $128.35.
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the business. BNP PARIBAS ASSET MANAGEMENT Holding S.A. acquired a new position in shares of Innospec during the second quarter valued at about $28,000. Tsfg LLC acquired a new position in shares of Innospec during the first quarter valued at about $35,000. EverSource Wealth Advisors LLC grew its holdings in shares of Innospec by 1,159.5% during the second quarter. EverSource Wealth Advisors LLC now owns 529 shares of the specialty chemicals company's stock valued at $44,000 after buying an additional 487 shares during the last quarter. Blue Trust Inc. grew its holdings in shares of Innospec by 38.3% during the second quarter. Blue Trust Inc. now owns 672 shares of the specialty chemicals company's stock valued at $57,000 after buying an additional 186 shares during the last quarter. Finally, Covestor Ltd grew its holdings in shares of Innospec by 13.9% during the fourth quarter. Covestor Ltd now owns 967 shares of the specialty chemicals company's stock valued at $106,000 after buying an additional 118 shares during the last quarter. 96.64% of the stock is currently owned by institutional investors and hedge funds.
About Innospec
(
Get Free Report)
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
See Also

Before you consider Innospec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.
While Innospec currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.